Brief: Incannex Healthcare Says Engages Eurofins To Manufacture Renecann Therapeutic
29/11/2022 01:33
Nov 29 (Reuters) - Incannex Healthcare Ltd IHL.AX :
* ENGAGES EUROFINS TO MANUFACTURE RENECANN THERAPEUTIC
TOPICAL
APPLICATION FOR IMMUNE DISORDERED SKIN DISEASES
Source text for Eikon: ID:nASX8KrLlB
Further company coverage: IHL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed